TY  - GEN
AU  - Pietanza,M C
AU  - Hellmann,Matthew D
AU  - Fiore,John J
AU  - Smith-Marrone,Stephanie
AU  - Basch,Ethan M
AU  - Schwartz,Lawrence H
AU  - Ginsberg,Michelle S
AU  - Shouery,Marwan
AU  - Newman,Samantha K
AU  - Shaw,Mary
AU  - Rogak,Lauren J
AU  - Lash,Alex E
AU  - Hilden,Patrick
AU  - Kris,Mark G
TI  - Phase II Study of a Non-Platinum-Containing Doublet of Paclitaxel and Pemetrexed with Bevacizumab as Initial Therapy for Patients with Advanced Lung Adenocarcinomas
SN  - 1556-1380
PY  - 2017///1107
KW  - Adenocarcinoma
KW  - drug therapy
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Bevacizumab
KW  - administration & dosage
KW  - Brain Neoplasms
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Paclitaxel
KW  - Pemetrexed
KW  - Prognosis
KW  - Proto-Oncogene Mas
KW  - Survival Rate
N1  - Publication Type: Clinical Trial, Phase II; Journal Article
UR  - https://doi.org/10.1016/j.jtho.2016.02.018
ER  -